This is the bill as Congress filed it, with every figure linking back to the official record. Say how you\u2019d vote on it before the floor vote happens, and VoteWire will show you what your own representatives did. How it works →
To amend the Federal Food, Drug, and Cosmetic Act to permanently extend the authority of the Secretary of Health and Human Services to award priority review vouchers for rare pediatric disease products.
Latest action (Sep 14, 2026) — on Energy and Commerce.
What it does
not written yetThe Congressional Research Service writes the plain-English summary for every bill, usually a few weeks after it's introduced. This one doesn't have one yet. It will appear here when it does.
In the meantime the most reliable description is the bill's own official title, which is the heading above — written by its sponsor, and the only account of the bill that exists at this stage. The full text is on congress.gov ↗
We don't write our own summaries. Everything else on this site links back to a record you can check, and a description of a bill that came from us rather than from the bill would be the one thing here that didn't — on the page that asks you to take a position on it.
Who lobbied on this
2 organizationsThese organizations told Congress, in their own quarterly disclosures, that they were lobbying on this bill.
- Biotechnology Innovation Organizationno position stated
“…Infectious Diseases ---VICP/CICP Capital Formation Incentives ---Net Operating Loss Advance Refunds Orphan Drug Issues ---H.R.1414: Cameron's Law ---H.R.10359: Priority for Pediatric Cures Act Pandemic Preparedness Research & Development Tax Credit Reforms ---H.R.1: One Big Beautiful Bill Act…” filing ↗
- Lundbeck LLCno position stated
“…pertaining to transparency - HR 9393, Lower Costs, More Transparency Act Issues pertaining to Pediatric Priority Review Voucher program at the FDA - H.R.10359, Priority for Pediatric Cures Act” filing ↗
Most filings say only that an organization lobbied on a bill, not which side it took — where that's the case we say so rather than guessing. Quotes are verbatim from the filing. How this is built.
Discussion
0 commentsSign in to join the discussion and put your vote on the record.
No comments yet. Be the first to make the case.